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Abstract
Background: As well as being inducible by haem, haemoxygenase -1 (HO-1) is also induced by interleukin-10 and an anti-inflammatory
prostaglandin, 15d PGJ2, the carbon monoxide thus produced mediating the anti-inflammatory effects of these molecules. The cellular
distribution of HO-1, by immunohistochemistry, in brain, lung and liver in fatal falciparum malaria, and in sepsis, is reported.
Methods: Wax sections were stained, at a 1:1000 dilution of primary antibody, for HO-1 in tissues collected during paediatric autopsies
in Blantyre, Malawi. These comprised 37 acutely ill comatose patients, 32 of whom were diagnosed clinically as cerebral malaria and the
other 5 as bacterial diseases with coma. Another 3 died unexpectedly from an alert state. Other control tissues were from Australian
adults.
Results: Apart from its presence in splenic red pulp macrophages and microhaemorrhages, staining for HO-1 was confined to intravascular
monocytes and certain tissue macrophages. Of the 32 clinically diagnosed cerebral malaria cases, 11 (category A) cases had negligible
histological change in the brain and absence of or scanty intravascular sequestration of parasitized erythrocytes. Of these 11 cases, eight
proved at autopsy to have other pathological changes as well, and none of these eight showed HO-1 staining within the brain apart from
isolated moderate staining in one case. Two of the three without another pathological diagnosis showed moderate staining of scattered
monocytes in brain vessels. Six of these 11 (category A) cases exhibited strong lung staining, and the Kupffer cells of nine of them were
intensely stained. Of the seven (category B) cases with no histological changes in the brain, but appreciable sequestered parasitised
erythrocytes present, one was without staining, and the other six showed strongly staining, rare or scattered monocytes in cerebral
vessels. All six lung sections not obscured by neutrophils showed strong staining of monocytes and alveolar macrophages, and all six
available liver sections showed moderate or strong staining of Kupffer cells. Of the 14 (category C) cases, in which brains showed micro-
haemorrhages and intravascular mononuclear cell accumulations, plus sequestered parasitised erythrocytes, all exhibited strong monocyte
HO-1 staining in cells forming accumulations and scattered singly within cerebral blood vessels. Eleven of the available and readable 13 lung
sections showed strongly staining monocytes and alveolar macrophages, and one stained moderately. All of the 14 livers had strongly
stained Kupffer cells. Of five cases of comatose culture-defined bacterial infection, three showed a scattering of stained monocytes in
vessels within the brain parenchyma, three had stained cells in lung sections, and all five demonstrated moderately or strongly staining
Kupffer cells. Brain sections from all three African controls, lung sections from two of them, and liver from one, showed no staining for
HO-1, and other control lung and liver sections showed few, palely stained cells only. Australian-origin adult brains exhibited no staining,
whether the patients had died from coronary artery disease or from non-infectious, non-cerebral conditions
Conclusions: Clinically diagnosed 'cerebral malaria' in children includes some cases in whom malaria is not the only diagnosis with the
hindsight afforded by autopsy. In these patients there is widespread systemic inflammation, judged by HO-1 induction, at the time of death,
but minimal intracerebral inflammation. In other cases with no pathological diagnosis except malaria, there is evidence of widespread
inflammatory responses both in the brain and in other major organs. The relative contributions of intracerebral and systemic host
inflammatory responses in the pathogenesis of coma and death in malaria deserve further investigation.
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Falciparum malaria is a complex multi-organ disease.
There is no simple or accepted explanation for how small
numbers of parasites can cause such severe illness, or how
this infection can cause such wide-spread pathology, since
only hepatocytes and erythrocytes are invaded by the
pathogen. Undoubtedly parasitized red cells sequester in
capillaries and venules, but in recent times the traditional
idea that this is the primary cause of organ failure and
death through obstructing blood flow has needed modi-
fying. In particular, it has had to accommodate the evi-
dent involvement of excessive systemic release of pro-
inflammatory cytokines, triggered by malarial toxins. For
the last decade, many researchers have focussed their
efforts on the pathophysiological implications of the abil-
ity of these mediators to generate inducible nitric oxide
synthase (iNOS), and thus produce a continuous, poten-
tially large, supply of nitric oxide in tissues that normally
experience only low, tightly controlled, levels of this ubiq-
uitous cellular messenger. Despite the harmful effects of
iNOS-induced nitric oxide (NO) when produced in unu-
sually large amounts [1-3], more commonly it provides
negative feedback that suppresses production of the
inflammatory cytokines that generate it, and a range of
other downstream harmful mediators, through inhibiting
NF kappa B, a major activator of protein transcription [4].
Carbon monoxide (CO), another endogenous gas with a
similar structure, also inhibits TNF generation [5] again
through inhibiting NF kappa B [6]. Both molecules are
generated by enzymes that have at least one constitutive
form, and another, iNOS and haemoxygenase-1 (HO-1)
respectively, induced by inflammatory cytokines. NO and
CO act interactively as second messengers in ways that are
still being elucidated [7]. For instance, both NO and CO
can activate soluble guanylate cyclase to generate cyclic
GMP [8], and thus dilate blood vessel walls, as well as per-
form their immunosuppressive roles.
This shared activity of NO and CO duplicates that of inter-
leukin-10 (IL-10), the prototype anti-inflammatory
cytokine, which also suppresses generation of tumour
necrosis factor (TNF) and interleukin-1β through inhibit-
ing NF kappa B [9]. Thus the high circulating levels of IL-
10 seen in human malaria [10,11] and sepsis [12], have
been proposed to suppress disease severity through inhib-
iting the systemic inflammatory effects of TNF [13]. These
apparently disparate observations are now appreciated to
be different parts of the same chain of events, with IL-10
producing its strong anti-TNF effect through inducing
HO-1, and thus generating CO [14]. The most plausible
explanation for the early observation that TNF induces
HO-1 [15] is now therefore its ability to induce IL-10 [16].
Likewise, the anti-inflammatory effect of 15d prostaglan-
din J2 (15d PGJ2), which is present in tissues during
inflammation [17], also operates through HO-1 induc-
tion and subsequent generation of CO [18]. As in sepsis,
cyclooxygenase-2, which generates 15d PGJ2, is induced
in severe malaria [19]. Thus, rather than HO-1 simply
being a marker for haem degradation and a generator of
anti-oxidant defences, it is now recognized to be an inte-
gral part of the network of inflammatory mediators. It
therefore serves as a convenient and sensitive marker for
such activity.
Accordingly, brain, lung and liver from 40 African chil-
dren who had died of malaria, sepsis or unrelated condi-
tions were stained for HO-1 in order to identify cellular
sites where the CO-mediated anti-inflammatory activity
of IL-10 might be located in these infectious diseases.
These tissues had previously been stained for migration
inhibitory factor (MIF) and inducible nitric oxide syn-
thase (iNOS) [20]. Before the IL-10 or prostaglandin links
of HO-1 were appreciated, others [21,22] have immunos-
tained brains, but no other tissues, from adult malaria
cases, to detect this enzyme. The present study provides
further evidence for the presence of multi-organ inflam-
matory changes in children fulfilling the clinical criteria of
'cerebral malaria', whether or not malaria was the princi-
pal or only pathological diagnosis.
Materials and Methods
Case Tissues
As described earlier [20], all 40 subjects (age range six
months to 12 years; 22 females) were children who had
been admitted to the Malaria Project wards in the Depart-
ment of Paediatrics at the Queen Elizabeth Central Hospi-
tal in Blantyre, Malawi (Table). Evaluation, diagnoses,
treatment, autopsy permissions were as previously
described [20]. Autopsies were performed as quickly after
death as possible, with post-mortem intervals ranging
from two to 14.5 hrs. Tissue samples were placed into
10% neutral buffered formalin for fixation. The project
was approved by the ethics and research boards of the
College of Medicine (University of Malawi), the Univer-
sity of Liverpool and the Australian National University.
Control tissues
Tissues from three Malawian children who were enrolled
in this study served as local non-comatose controls. No
coma was present at any stage in two of these (patients 41
and 50; see Table). The former grew Salmonella typhimu-
rium from cerebrospinal fluid and blood, and died, hav-
ing been alert a short time before, after an acute
gastrointestinal haemorrhage, and the other grew scanty
Streptococcus pneumoniae from the cerebrospinal fluid. The
third (patient 43) had been diagnosed as cerebral malaria
but, after recovering to an alert state, died from a cardiop-
ulmonary arrest. In addition, various adult controls from
Australian sources were studied. These comprised sectionsPage 2 of 13
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tumour excisions from adult chest wall, and containing
skeletal muscle, adipose tissue and small blood vessels.
Midbrain sections from three adults who had died of cor-
onary artery disease, and from another three who died of
non-infectious, non-cerebral conditions (Brain Bank for
Sydney Central Area Health Science Approval X980216),
were also stained. A section of an inflamed pilonidal sinus
was routinely included as a positive control.
Immunohistochemistry
Formalin-fixed tissue samples were embedded in paraffin,
sectioned (4 microns) on to polylysine-coated slides, and
stained with haematoxylin and eosin (H&E) for routine
morphology. A monoclonal anti-HO-1 antibody was pur-
chased from StressGen; (Cat. No. OSA-110). Other mon-
oclonals were used as irrelevant primary control
antibodies, and in other controls the primary antibody
was omitted. As previously [20], antigen retrieval was per-
formed by immersion in 0.01 M citrate buffer, pH 6.0, in
a waterbath at 95°C for 20 min and then cooling to room
temperature while still immersed in buffer. After quench-
ing with 3% H2O2 and treating with primary antibody
(dilution of the stock solution 1:500 to 1:2000) at room
temperature for 1 hr, biotin-conjugated secondary anti-
body and streptavidin-conjugated horseradish peroxidase
from an LSAB+ kit (DAKO) were applied to sections for 20
min at room temperature to amplify the antigen signal for
subsequent 3,3'-diaminobenzidine (DAB) staining.
Known positive controls were stained in each run, and
runs were often duplicated on different days to confirm
repeatability. Sections were counterstained with haema-
toxylin, and outcomes with a dilution of primary anti-
body of 1:1000 are shown to illustrate the observed
changes. Anti-CD68 antibody (Clone PG-M1) was
obtained from DAKO, and used, with antigen retrieval, at
a primary antibody dilution of 1:500.
Histological examination
In a recent investigation of the distribution of MIF and
iNOS [20], in which 32 cases that had been clinically diag-
nosed as cerebral malaria were studied, they were classi-
fied into three categories on the basis of the presence or
absence of sequestered intracerebral parasites and brain
pathology. Category A (n = 11) had no or scanty intracer-
ebral parasites and negligible brain pathology detected,
category B (n=seven) had sequestered parasites in brain
vessels, again with negligible brain pathology, and cate-
gory C (n = 14) had both sequestered parasites and
inflammatory brain pathology in the form of intravascu-
lar monocyte aggregations, fibrin deposition and/or
microhaemorrhages. Here this same terminology is
retained, and the outcome of immunostaining to detect
HO-1 in the brain, lung and liver of these same cases is
reported. In most of the category A patients, autopsy
revealed another likely cause of death: this was pneumo-
nia in five cases, hepatic necrosis in one, severe anaemia
with pulmonary oedema in one, and ruptured cerebral
aneurysm in one. No alternative causes were identified in
category B and C patients.
One hundred and forty sections from 49 brains were
stained for HO-1 and examined. Samples were from fron-
tal lobe, parietal lobe, temporal lobe, occipital calcarine
fissure, hippocampus, caudate nucleus, basal ganglia, tha-
lamus, midbrain, pons and medulla, with frontal lobe,
occipital region, midbrain and pons most commonly
included. Two sections were considered ample to record a
result on sections where staining was readily detected,
since up to seven were examined in some cases, with no
difference in outcome from the opinion formed after the
first section. Up to seven sections per brain were examined
in those cases with no staining detectable, and these
comprised sections from two to four blocks, which pro-
vided an element of depth within individual blocks as
well as a spread of location across the brain. With few
exceptions, staining was either absent, moderate, or
strong, and if strong was sometimes remarkably intense
and even, despite the high dilution of primary antibody.
Mid-brain sections from three adults who had died of cor-
onary artery disease, and from another three who died of
non-infectious, non-cerebral conditions (Brain Bank for
Sydney Central Area Health Science Approval X980216),
were included. Single blocks only were available for lung
and liver. Two examiners (IC and CH), blinded to the
diagnosis, examined the sections independently.
Results
Cerebral malaria
Brain of the 32 cases clinically diagnosed as cerebral
malaria were examined after staining with anti-HO-1 anti-
body as described. Differences in degree of staining
between the various parts of the brain in any single indi-
vidual were slight to negligible, with the picture observed
in the first section examined holding true throughout the
series for that case. Staining was restricted to monocytes,
and where microhaemorrhages were present HO-1 was
detected in the macrophages that migrated into the imme-
diate area. In contrast to iNOS staining, a characteristic of
HO-1 detection was its either strong presence or absence,
with little between. Only single blocks of lung and liver
were available, and these stained uniformly across the sec-
tion. Staining in lung was restricted to monocytes and
alveolar macrophages, and in liver to Kupffer cells, except
for a very pale even stain across the parenchyma of a few
livers.Page 3 of 13
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Table 1: CM(A), insignificant physically apparent brain pathology
Patient no. Age (mo) Sex Parasitaemia 
(Pf) &/or 
Organism 
cultured
Admitting 
coma score
Parasites in brain 
vessels
Brain vessel 
monocyte HO-1
Lung mono & alveol 
M HO-1
Liver Kupffer cell 
HO-1
4 20 M 19% 2 1+ isolated, mod strong, fewer strong
7 29 F 4+ 0 1+ absent strong, fewer strong
22 18 M 2% 0 1+ absent strong, common strong
23 30 F 29% 0 1+ absent strong, common strong
31 39 M 49% 1 1+ absent PMN-obscured strong
33 25 M <1% 0 1+ absent pale strong
37 6 M 34% & P. mal. 
trace
2 1+ scattered, mod strong, fewer strong
38 84 F 22% 0 1+ scattered, mod strong, fewer strong
45 34 M 3% 0 1+ absent PMN-obscured moderate
47 22 F 11% 1 1+ absent pale strong
49 17 M 0% 1 1+ absent negative moderate
CM(B), sequestered parasites only
1 27 F 31% 0 2+ rare, strong mod, fewer strong
5 14 M 4% 1 4+ scattered, strong strong, common strong
16 51 F 6% 1 2+ rare, strong strong, fewer strong
21 25 F <1% 2 4+ scattered, strong strong, common strong
25 44 F <1% 2 4+ scattered, strong strong, common strong
39 18 M <1% 2 4+ scattered, strong strong, fewer strong
42 37 F 20% 0 4+ absent PMN-obscured NA
CM(C), sequestered parasites plus local intravascular inflammation
6 17 F 6% 0 3+ accumul, strong strong, common strong
9 16 M <1% 1 3+ accumul, strong strong, fewer strong
11 29 F 29% & H. influ. 
B
1 2+ accumul, strong PMN-obscured strong
13 22 M 37% 0–1 3+ scattered, strong strong, common strong
15 8 F 1% 2 2+ accumul, strong strong, fewer strong
26 30 M 19% 1 4+ accumul, strong strong, common strong
27 20 M 53% & Sal. 
typhi-m
0 3+ accumul, strong strong, fewer strong
28 61 F 23% 0 2+ scattered, strong NA strong
29 43 M 33% 2 3+ accumul, strong strong, fewer strong
32 18 F 47% 0 3+ accumul, strong strong, fewer strong
34 70 M 2% 1 4+ accumul, strong strong, common strong
35 114 M <1% 1 3+ accumul, strong strong, common strong
36 21 F 1% 2 2+ accumul, strong strong, fewer strong
48 48 M <1% 2 3+ accumul, strong mod, fewer strong
COMA (bacteria cultured, and clinically judged not cerebral malaria)
12 6 M Sal. enteritidis 2 negative scattered, strong strong strong, autolys
14 9 F E. coli 0 negative absent strong strong
18 7 F H. influenzae B 1 negative absent absent strong
20 96 F Tuberculosis 0 negative regionally strong regionally strong strong
24 48 F Strep. 
pneumoniae
3 negative rare, mod absent mod, autolysPage 4 of 13
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histological changes, only the occasional rare malarial
pigment or parasites within vessels, and in most cases an
additional explanation for death identified at general
autopsy) eight had no detectable HO-1 staining. in the
brain (Table 1). One showed isolated moderately stained
monocytes, and the other two showed a light scattering of
strongly stained monocytes across the brain parenchyma.
Examples are shown in Fig. 1. The identity of these cells
was confirmed with CD68 staining (not shown). Of the
11 lung sections, six exhibited strongly stained monocytes
and alveolar macrophages (Fig. 1), two were pale, and one
was negative. In the other two the section was largely
obscured by a heavy influx of neutrophils, a cell type we
have not seen stain for HO-1. Nine of the 11 liver sections
showed strongly staining Kupffer cells (Fig. 1), and in the
other two these cells were moderately stained only.
Category B cerebral malaria
In the seven category B cases (no discernible pathological
changes in the examined sections, but sequestered parasi-
tised erythrocytes present) 2 had rare strongly staining
monocytes in cerebral blood vessels, and another four
showed a scattering of strongly stained monocytes (Table
1). The identity of these cells was confirmed with CD68
staining (not shown) An example of each type of density
is shown in Fig. 2. Five out of seven lung sections showed
strong staining of monocytes and alveolar macrophages,
one was moderately stained, and the other section was
largely obscured by a heavy influx of neutrophils, with no
HO-1 staining discernible. All six of the available seven
liver sections showed strong staining of Kupffer cells,
again as illustrated in Fig. 2.
Category C cerebral malaria
The brains of 14 category C cases (microhaemorrhages,
intravascular mononuclear cell accumulations, and also
sequestered parasites) all exhibited strong monocyte HO-
1 staining in mononuclear leucocytes forming accumula-
tions, and also in those scattered singly, within blood ves-
sels (Table 1). The two cases illustrated in Fig. 3 had
neither a low haematocrit, nor hypoglycaemia. Monocyte
accumulations were not seen in sections of two of the
brains, and thus the individual cells are referred to in the
Table as "scattered, strong". In addition the macrophages
that had aggregated at microhaemorrhages were stained
strongly (Fig. 3). The identity of these cells was confirmed
with CD68 staining (not shown). Eleven of the 13 availa-
ble lung sections showed strongly staining monocytes and
alveolar macrophages (Fig. 3), with the monocytes often
in accumulations similar to those observed in the brain.
One section was moderately stained, and the other section
was largely obscured by a heavy influx of neutrophils. As
shown in the examples in Fig. 3, all of the 14 livers had
strongly stained Kupffer cells.
Coma associated with bacterial infections
Another five patients were comatose on admission and
before death, had very low or no peripheral malaria para-
sitaemia, and were considered on clinical grounds to be
suffering from a disease other than malaria [20]. Two had
septic meningitis (one each culture positive for Haemo-
philus influenzae and S. pneumoniae), two had a positive
blood culture (one Salmonella enteritidis, one Escherichia
coli) and one, with a lymphocytic infiltrate in the cerebro-
spinal fluid, was diagnosed histologically, including the
presence of acid-fast organisms, as tuberculous meningi-
tis. The E. coli and H. influenzae cases had no detectable
HO-1 staining. in the brain, and the other three showed a
variable scattering of stained monocytes (Table 1). In the
tuberculosis case staining was limited to the areas adja-
cent to large blood vessels. Two of the five lung sections
(S. enteritidis and E. coli cases) showed strongly staining
monocytes and alveolar macrophages, while none were
evident in the H. influenzae and S. pneumonia cases, and
they were restricted to the region near chronic lesions in
MALAWIAN CONTROLS (without terminal coma)
41 29 F Sal. 
typhimurium
5 negative absent absent absent
43 53 M suspect malaria 2, then 5 negative absent absent pale, v. occas
* 50 144 F Strep. 
pneumoniae
5 negative absent pale pale, occas
AUSTRALIAN CONTROLS
n= 6 F/
M
NA NA negative negative NA NA
* Serologically positive for HIV (n) Number of brains areas examined Abbreviations: NA = not applicable Sal. typhi-m. = Salmonella typhimurium H. 
influ. B = H. influenzae type B
Table 1: CM(A), insignificant physically apparent brain pathology (Continued)Page 5 of 13
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Malaria Journal 2003, 2 http://www.malariajournal.com/content/2/1/41CM (A). HO-1 staining of tissues from cerebral malaria cases showing apparently absent physical brain pathologyFigure 1
CM (A). HO-1 staining of tissues from cerebral malaria cases showing apparently absent physical brain pathol-
ogy. A and B brain, C and D lung, and E and F liver, the left hand column (A, C and E) being from case 22, an example of the 
more common (8 of 11) combination, in which cerebral vasculature monocytes were quiescent. B, D and F are from case 38. 
As in both examples, monocytes in lung, and Kupffer cells, were commonly (6 of 11 and 9 of 11 respectively) strongly stained. 
Scale bar, 100 µm.Page 6 of 13
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Malaria Journal 2003, 2 http://www.malariajournal.com/content/2/1/41CM (B). HO-1 staining of tissues from cerebral malaria cases showing apparently absent physical brain pathology, but seques-tered parasites commonFigure 2
CM (B). HO-1 staining of tissues from cerebral malaria cases showing apparently absent physical brain pathol-
ogy, but sequestered parasites common. A and B brain, C and D lung, and E and F liver. The left hand column (A, C and 
E) is from an example (case 25) of the more common (4 of 7) combination, in which cerebral vasculature monocytes were not 
common, though parasite sequestration sometimes intense. B, D and F are from case 21. As in both examples, monocytes in 
lung, and Kupffer cells, were commonly strongly stained. Scale bar, 100 µm.Page 7 of 13
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Malaria Journal 2003, 2 http://www.malariajournal.com/content/2/1/41CM (C). HO-1 staining of tissues from cerebral malaria cases showing physically apparent brain pathology, plus sequestered parasites presenFigure 3
CM (C). HO-1 staining of tissues from cerebral malaria cases showing physically apparent brain pathology, plus 
sequestered parasites present. A and B brain, C and D lung, and E and F liver. Both case 9 (A, C and E) and case 26 (B, D 
and F) show the brain monocyte, lung monocyte and macrophage, and Kupffer cell staining that dominate this group. Scale bar, 
100 µm.Page 8 of 13
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of the Kupffer cells, although in one case this was moder-
ate rather than strong (Table 1). As examples, the changes
in brain, lung and liver of the E. coli and H. influenzae
cases are shown in Fig. 4.
Control Tissues
Brain sections from all three African controls, and lung
sections from two of them, and the liver of one, showed
no staining for HO-1 (Table 1, Fig. 5). The lung of the one,
and the liver of two, showed few, palely stained cells only.
Likewise, the 6 Australian-origin adult brains showed no
staining, whether the patients had died from coronary
artery disease or non-infectious, non-cerebral conditions
(Fig. 5G). The subcutaneous tissues from Australian adult
controls were also negative (not shown). In contrast, mac-
rophages in the section of inflamed pilonidal sinus
included in every staining run invariably were strongly
positive (Fig. 5H), as were the macrophages in the splenic
red pulp, a location where free haem can be expected to
induce HO-1, in all African cases (not shown).
CD 68 staining
CD36 staining confirmed the identity of the mononuclear
phagocytic lineage of stained cells, including the cells
attracted to ring haemorrhages, that were positive for HO-
1. Both single and double staining was undertaken (not
shown). This confirmed that negative HO-1 staining of
tissues could not be attributed to an absolute absence of
monocytes and macrophages in various locations, but to
them being present and not staining.
Discussion
Here is described the cellular distribution of HO-1 in sev-
eral key organs in African children who died of clinically
defined cerebral malaria or coma accompanying a bacte-
rial infection. Endothelial cells and vascular smooth mus-
cle, and skeletal muscle, so often MIF and iNOS positive
[20], were devoid of HO-1. Previous reports of HO-1
staining of human tissues includes the cytotrophoblast
cells within the placental bed of the normal human pla-
centa [23], the alveolar macrophages of normal and
inflamed lung [24], endothelium and macrophages of
atherosclerosis lesions [25], Kupffer cells and hepatocytes
in portal hypertension [26], tubular epithelial cells in kid-
ney diseases [27], and microglia and macrophages in focal
cerebral infarcts and brain trauma [28]. Malarial brains,
but no other organ, from Asian [22] and European adults
[21] have been stained for HO-1, and, consistent with the
literature of the time, HO-1 was discussed only in terms of
being a stress protein [22] and a generator of CO that
could contribute to cerebral malaria by influencing neu-
rons directly [21].
What induced HO-1 in these tissues remains unclear. It is
well accepted that a high concentration of haem induces
HO-1 [29], and the invariable staining observed in spleen
red pulp in all cases (not shown), and at cerebral haemor-
rhage sites where red cells have been phagocytosed (Fig.
3B) in category C brains is consistent with this. Haem
from local haemorrhage cannot, however, account for the
presence of HO-1 in mononuclear phagocytes in CM(A)
or CM(B) brains, and other organs In addition, cellular
deprivation of glucose has been shown to induce the HO-
gene 1 in vitro [30], raising the possibility of the hypogly-
caemia sometimes seen in severe childhood falciparum
malaria being instrumental in generating the observed
HO-1. No difference was seen in the intensity of HO-1
staining between cases with normal peripheral blood glu-
cose concentration and those with systemic hypoglycae-
mia, but this observation does not exclude local tissue
hypoglycaemia as a possible stimulus to HO-1 induction.
IL-10, a major modulator of inflammation increased in
malaria [10], is now known to induce HO-1 [14]. Plasmas
for IL-10 assay were not available from these cases, but the
precedence exists of high levels being associated with
severe malarial illness [10,11].
In view of the evidence that the inflammatory cascade is
activated in this Malawian [20,31] and other [32-34] pop-
ulations with severe malaria infection, the observed HO-1
is additional evidence that in fatal malaria a widespread
host inflammatory response occurs, similar to that seen in
other acute infections (reviewed in [35]). This is consist-
ent with the HO-1 staining seen in the sepsis cases in this
series (Fig. 4), in that systemic bacterial infections are
broadly accepted to be examples of systemic inflamma-
tion. This is not to suggest that some of the cerebral
malaria cases in this series did not have additional or
alternative disease mechanisms, arising from local cere-
bral lesions, such as vessel obstruction from large parasite
loads in the apparent absence of other lesions (Fig. 2B).
Nevertheless, strong systemic inflammation was present
in all these cases. Local cerebral changes arising from post-
schizogony secondary inflammatory events, as demon-
strated by the presence of monocytes accumulations, high
iNOS, haemorrhages and fibrin in other CM(C) cases (Fig.
3A and 3B) may well also contribute significantly.
Taken with the evidence that eight of the 11 category A
brains had no evidence of HO-1 staining, these results,
along with the apparent absence of sequestration or
monocytic accumulation (now reinforced by examining
this large series of new sections) and iNOS staining in
these same brains [20], add to previous evidence [20] that
these 11 sets of brains sections, one third of the total from
clinically diagnosed cases of cerebral malaria, were largely
devoid of significant intravascular change. These patients,
together with those in the group of patients with non-Page 9 of 13
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HO-1 staining of tissues from bacterial sepsis cases. A and B brain, C and D lung, and E and F liver. Case14 (A, C and 
E), an E. coli infection, demonstrates no brain monocyte activity (A), but pulmonary monocytes and macrophages (C), and 
Kupffer cells (E) stained strongly. While case 18 (B, D and F), a H. influenzae infection, had no HO-1 staining in the brain or 
lung, Kupffer cells stained strongly. Scale bar, 100 µm.Page 10 of 13
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HO-1 staining of tissues from controls. A and B brain, C and D lung, and E and F liver of African controls, cases 41 (A, 
C and E) and 43 (B, D and F). Australian origin coronary artery disease brain (G) and chronically infected pilonidal sinus (H) 
are also shown. Pattern shown was the same in all cases illustrated. Scale bar, 100 µm.Page 11 of 13
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may accompany infections with extensive systemic
inflammation but without evidence of intracerebral
inflammatory responses. It is, therefore, possible that, in
the CM(B) and CM(C) patients (with cerebral sequestra-
tion and cerebral intravascular HO-1 induction), the
observed widespread systemic inflammation may have
been similarly important in the pathogenesis of coma.
This adds strength to the argument that systemic events,
not only those in the brain, should be borne in mind
when attempting to understand disease outcome in Afri-
can children clinically diagnosed with cerebral malaria.
The CM(A) group, one third of the cases, in which malaria
was only one of several conditions that could have con-
tributed to death, might have provided insight into the
state the cerebral vasculature of the CM(B) and CM(C)
cases after they had become comatose, but some time
before death.
Finally, the inhibitory activity of CO, the product of HO-
1, against TNF [4] parallels that of NO, the product of
iNOS [5]. Ideas on how iNOS polymorphisms might have
been selected for in African populations [36,37] through
their interaction with malarial disease might also, from
these results, apply to known HO-1 polymorphisms
[38,39] in these populations.
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